Maxygen, Inc.

Roche Palo Alto LLC

Cytomx Therapeutics, Inc.

Bayer Healthcare LLC

Astellas Pharma Gmbh

Perseid Therapeutics LLC

Sridhar Viswanathan

Phillip A Patten

Torben Lauesgaard Nissen

Stefan Seeber

Stephan Fischer

Sridhar Govindarajan

Juha Punnonen

Ralf Schumacher

Anne Vogt

Harald Kropshofer

Andreas Schaubmar

Hans Koll

Roberto Falkenstein

Adelbert Grossmann

Erik E Karrer

Friederike Hesse

Madan M Paidhungat

Margaret Neighbors

Steven J Chapin

Sarah Patrick

Shanti Gonela Duvur

Eric Ureno

Claus Krebber

The invention provides a composition including an intact activatable antibody and a clipped variant thereof, methods of separating clipped variants of intact activatable antibodies from intact activatable antibodies and related methods including methods for determining or monitoring a relative percentage of an activatable antibody and a clipped variant thereof during a composition production process.

Compositions containing activatable antibodies

The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.

Interferon-alpha polypeptides and conjugates

Growing community of inventors

Menlo Park, CA, United States of America

Sridhar Viswanathan